SCHEMBL27190053

SCHEMBL27190053

COc1ccc(Cl)cc1NC=C1C(=O)OC(C)(C)OC1=O

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 17/20 0.74
HSD17B10 Q99714 5/20 0.74
CASP1 P29466 2/20 0.74
CASP7 P55210 2/20 0.74
NPSR1 Q6W5P4 3/20 0.57
HPGD P15428 2/20 0.57
KDM4E B2RXH2 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
MAPK1 P28482 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.50
KMT2A Q03164 4/20 0.49
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
GAA P10253 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 2/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 2/20 0.45
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30626621 1.00 ALDH1A1 (0.74) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL10158686 0.85 ALDH1A1 (1.00) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL24715839 0.84 ALDH1A1 (0.74) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL10075563 0.82 ALDH1A1 (1.00) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL25421746 0.81 ALDH1A1 (0.57) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL25420449 0.80 ALDH1A1 (0.59) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL16431500 0.79 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL25419587 0.78 ALDH1A1 (0.54) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL25420430 0.78 ALDH1A1 (0.68) ALDH1A1HSD17B10CASP1CASP7NPSR1
SCHEMBL24715775 0.78 ALDH1A1 (0.46) ALDH1A1HSD17B10CASP1CASP7NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623914-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE Jiangsu Yahong Meditech Co., Ltd. (CN) 2025-10-01 EP disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
WO-2024109684-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE 江苏亚虹医药科技股份有限公司 2024-05-30 WO disclosed
CN-118059101-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2024-05-24 CN disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed
CN-117043141-A 7-nitro-8-hydroxyquinoline derivative, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-11-10 CN disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 ALDH1A1 1017/4885HSD17B10 660/4885CASP1 608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.